The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jun. 20, 2023
Filed:
May. 19, 2016
Applicant:
The Regents of the University of California, Oakland, CA (US);
Inventors:
Christopher S. Seet, Santa Monica, CA (US);
Gay Miriam Crooks, Sherman Oaks, CA (US);
Assignee:
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA, Oakland, CA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12N 5/10 (2006.01); C12N 5/0784 (2010.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
C12N 5/0639 (2013.01); A61K 39/0011 (2013.01); A61K 39/00115 (2018.08); A61K 39/00117 (2018.08); A61K 39/001104 (2018.08); A61K 39/001106 (2018.08); A61K 39/001108 (2018.08); A61K 39/001109 (2018.08); A61K 39/001122 (2018.08); A61K 39/001149 (2018.08); A61K 39/001151 (2018.08); A61K 39/001153 (2018.08); A61K 39/001156 (2018.08); A61K 39/001157 (2018.08); A61K 39/001164 (2018.08); A61K 39/001168 (2018.08); A61K 39/001171 (2018.08); A61K 39/001172 (2018.08); A61K 39/001182 (2018.08); A61K 39/001186 (2018.08); A61K 39/001188 (2018.08); A61K 39/001191 (2018.08); A61K 39/001192 (2018.08); A61K 39/001193 (2018.08); A61K 39/001194 (2018.08); A61K 39/001195 (2018.08); A61K 39/001197 (2018.08); A61K 2039/5154 (2013.01); C12N 2500/30 (2013.01); C12N 2501/125 (2013.01); C12N 2501/145 (2013.01); C12N 2501/22 (2013.01); C12N 2501/2303 (2013.01); C12N 2501/26 (2013.01); C12N 2501/42 (2013.01); C12N 2501/998 (2013.01); C12N 2502/1121 (2013.01); C12N 2502/1171 (2013.01); C12N 2502/1352 (2013.01);
Abstract
In various embodiments methods of producing a cell population enriched for CLEC9A+ dendritic cells are provided where the methods involve culturing stem cells and/or progenitor cells in a cell culture comprising culture medium, a notch ligand, stem cell factor (SCF), FLT3 ligand (FLT3L); thrombopoietin (TPO); and IL-3 and/or GMCSF.
Seet, Christopher. (2023). Method for generating human dendritic cells for immunotherapy (U.S. Patent No. 11680244). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/11680244
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile